JANUARY 2014
Highlights
First issue of this year 2014 and we are going to write new chapter in pharma & lifescience world. This year will be the best for pharma job seekers because it looks like job outcomes may increase this year.
This issue straightly highlighting on, what possibly can be new pharma blockbuster molecule after Lipitor. As increasing rate of problems associated with obesity and everyone love to be slim and fit, so it is well predicted that any such new patent with no or lessrer side effects will create notable history in pharma era.
Though lots of talk and research is going on nanotechnology and still it is in developing stage. And in article on nanotechnology, author expressed present therapies and devices of nanotechnology and optimistic about future that we could imagine a world where medical nano devices are routinely implanted or even injected into the bloodstream to monitor wellness and to automatically participate in the repair of systems that deviate from established norms.
There are also reviews on Portrayal of a Drug, Pharmacological Updates of Pistia Stratiotes, Tilling Techniques, Drug Induced Mitochondrial Toxicity, Pyrazole, Ocular Drug Delivery, Activity of chalcones, Indole alkaloids in cancer, Dendrimer and Herbs & Spices.
This issue is also highlighting important researches on Combination Treatment with ARB+HCTZ and ACEs+HCTZ in hypertensive patient, Formulations of Sustained Release Pellets of Venlafaxine HCl and Preliminary Assessment of Nigerian Herbal Formula Ekpo Aganwo.